Smart Blood Pressure Monitoring Devices Market (2026 - 2033)

Smart Blood Pressure Monitoring Devices Market Summary

The global smart blood pressure monitoring devices market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 3.6 billion by 2033, at a CAGR of 12.0% from 2026 to 2033.North America dominated the market, accounting for a revenue share of 42.4% in 2025.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The growth of the smart blood pressure monitoring devices industry is attributed to the increasing adoption of connected blood pressure monitoring for chronic disease management, the growing integration of smart blood pressure monitors with remote patient monitoring (RPM) platforms, and the rising demand for smartphone-enabled home blood pressure monitoring.

To learn more about this report, Download Free Sample Report

Market Dynamics

The smart blood pressure monitoring devices market is driven by the rising prevalence of hypertension and cardiovascular diseases, as well as the growing adoption of connected healthcare technologies for continuous blood pressure monitoring. Rising demand for remote patient monitoring, telehealth services, and home-based chronic disease management is accelerating the use of Bluetooth-, Wi-Fi-, and cellular-enabled blood pressure monitors that enable real-time data sharing between patients and healthcare providers.

In addition, continuous advancements in digital health technologies, including AI-powered analytics, cloud connectivity, and integration with mobile health applications, are improving monitoring accuracy, patient engagement, and clinical decision-making. Growing awareness of preventive healthcare and the increasing preference for home-based monitoring solutions are further supporting the adoption of smart blood pressure monitoring devices across both developed and emerging healthcare markets.

“OMRON Healthcare is evolving the blood pressure monitoring experience by making AFib screening an integral part of every measurement. AFib is a serious condition that is widely undiagnosed. With Intellisense AFib, we are working to help anyone who uses our blood pressure monitors detect this condition earlier so they can reduce the associated stroke, heart failure and dementia risks.”

- OMRON Healthcare U.S. Managing Director Alice Koehler.

Market Concentration & Characteristics

The degree of innovation in the smart blood pressure monitoring devices market is high, driven by continuous advancements in artificial intelligence (AI), wireless connectivity, cloud-based health platforms, and digital health integration. For instance, in July 2025, Runstar introduced its new Smart Blood Pressure Monitor, designed for convenient at-home health tracking. The device features Bluetooth connectivity, automatic synchronization with a companion mobile application, multi-user data management, and long-term blood pressure trend analysis, enabling users to share health data with healthcare providers for remote monitoring .

"At RunStar, we are dedicated to empowering people to take proactive control of their health by making high-quality health data a normal part of daily life, rather than an intimidating hurdle, This new version of the blood pressure monitor is designed to fit seamlessly into any lifestyle, making advanced health insights, such as cardiovascular health, both simple and accessible."

-            Frank Li, Founder of RunStar

The level of partnerships and collaboration activities in the market is high, as manufacturers increasingly collaborate with digital health companies, AI developers, and remote patient monitoring providers to expand connected healthcare solutions. These partnerships accelerate the development of AI-enabled blood pressure monitoring technologies by integrating wearable devices, cloud platforms, and telehealth solutions. For instance, in November 2025, Omron Healthcare strengthened its strategic partnership with Sky Labs Inc., a South Korea-based digital health company, by signing a Memorandum of Understanding (MoU) and making an investment through Omron Ventures . The collaboration focuses on advancing cuffless blood pressure monitoring technology by combining Omron's expertise in cardiovascular healthcare with Sky Labs' CART BP, a ring-type wearable blood pressure monitoring device.

To learn more about this report, Download Free Sample Report

The impact of regulations on the global smart blood pressure monitoring devices market is significant, as governments and regulatory authorities continue to strengthen requirements related to medical device safety, software validation, cybersecurity, wireless connectivity, and patient data privacy. Regulations such as the U.S. FDA's medical device regulations, the Medical Device Regulation (MDR) in Europe, and data privacy frameworks, including HIPAA and GDPR, require manufacturers to ensure the safety, accuracy, cybersecurity, and secure transmission of patient health data. Although these regulatory requirements increase product development costs and approval timelines, they also enhance user confidence, support interoperability with digital health platforms, and encourage the adoption of reliable smart blood pressure monitoring devices for home healthcare and remote patient monitoring.

The smart blood pressure monitoring devices industry is expanding as key players strengthen their presence through investments in connected healthcare technologies, digital health ecosystems, and remote patient monitoring solutions. Companies are expanding their regional distribution networks, launching localized smart blood pressure monitoring devices, and forming strategic partnerships with healthcare providers and telehealth platforms to increase market penetration.

Analyst Perspective

The integration of Bluetooth, Wi-Fi, and cellular-enabled technologies with mobile health applications and cloud platforms is improving continuous blood pressure monitoring and enabling real-time data sharing between patients and healthcare providers. Companies are focusing on developing AI-enabled blood pressure monitors, enhancing connectivity and interoperability with digital health ecosystems, and introducing advanced features such as irregular heartbeat detection, personalized health insights, and cloud-based data management. They are also investing in strategic partnerships, product launches, and mobile health platform integration to strengthen their presence in the expanding smart healthcare market.

Type Insights

The upper arm blood pressure monitor segment dominated the market with a revenue share of 59.9% in 2025, owing to its superior measurement accuracy, clinical reliability, and widespread recommendations from healthcare professionals. These devices are extensively used for hypertension diagnosis and long-term cardiovascular disease management in both home care and clinical settings. Their compatibility with Bluetooth, Wi-Fi, and remote patient monitoring platforms, along with integration into mobile health applications, has further strengthened their adoption among patients and healthcare providers.

The wrist blood pressure monitor segment is expected to grow at the fastest CAGR of 12.7% during the forecast period from 2026 to 2033. This growth is driven by increasing consumer preference for compact, portable, and easy-to-use monitoring devices. These monitors offer greater convenience for frequent blood pressure measurements, making them well-suited for active users and home healthcare. Continuous improvements in sensor technology, connectivity features, and measurement accuracy, along with growing adoption of smartphone-connected health devices, are further supporting the rapid growth of this segment.

Technology Insights

The Bluetooth-based segment dominated the smart blood pressure monitoring devices market with a revenue share of 55.2% in 2025. This dominance is due to the widespread adoption of Bluetooth technology, its affordability, and seamless integration with smartphones and mobile health applications. Bluetooth-enabled devices allow users to automatically sync blood pressure readings with companion apps for long-term tracking, trend analysis, and data sharing with healthcare providers. Their low power consumption, ease of use, and compatibility with remote patient monitoring platforms have made them the preferred connectivity option for home blood pressure monitoring.

The cellular-enabled devices (4G/5G) are expected to grow at the fastest CAGR during the forecast period from 2026 to 2033. The increasing adoption of remote patient monitoring and chronic disease management programs. Unlike Bluetooth-enabled devices, cellular-connected monitors transmit blood pressure readings directly to cloud platforms without requiring a smartphone or Wi-Fi connection, making them suitable for elderly patients and individuals with limited digital literacy. Growing demand for continuous remote monitoring, expansion of telehealth services, and advancements in 4G/5G connectivity are driving the adoption of cellular-enabled smart blood pressure monitoring devices.

End Use Insights

The hospitals segment led the smart blood pressure monitoring devices industry with the largest revenue share of 48.7% in 2025. This is due to the high volume of patients requiring continuous blood pressure monitoring for hypertension, cardiovascular diseases, and post-operative care. Hospitals are increasingly adopting smart blood pressure monitors integrated with electronic health records, remote patient monitoring platforms, and hospital information systems to improve clinical workflow, enable real-time patient monitoring, and support timely treatment decisions. The availability of advanced healthcare infrastructure and higher investment in connected medical devices further support the segment's dominance.

To learn more about this report, Download Free Sample Report

The home care settings segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing preference for home-based chronic disease management and remote patient monitoring. Rising adoption of Bluetooth-, Wi-Fi-, and cellular-enabled blood pressure monitors allows patients to measure and securely share blood pressure readings with healthcare providers without visiting healthcare facilities. Growing awareness of preventive healthcare, expansion of telehealth services, and the increasing elderly population are further accelerating the adoption of smart blood pressure monitoring devices in home care settings.

Regional Insights

North America dominated the smart blood pressure monitoring devices market in 2025 with a revenue share of 42.4%. This dominance is driven by the high prevalence of hypertension, widespread adoption of remote patient monitoring (RPM), favorable reimbursement for connected healthcare services, and strong penetration of digital health technologies. The presence of leading manufacturers such as Omron Healthcare, iHealth Labs, and Smart Meter, along with increasing consumer adoption of connected home healthcare devices, continues to support market growth.

To learn more about this report, Download Free Sample Report

For instance, in August 2025, Omron Healthcare launched a nationwide initiative in the U.S. encouraging routine at-home blood pressure monitoring following the updated American Heart Association (AHA) and American College of Cardiology (ACC) hypertension guidelines. The initiative promoted the use of connected blood pressure monitors integrated with the OMRON Connect app and AI-powered AFib detection, reinforcing the growing adoption of smart home monitoring and remote cardiovascular care across North America.

U.S. Smart Blood Pressure Monitoring Devices Market Trends

The U.S. smart blood pressure monitoring devices industry dominated North America in 2025, driven by the increasing adoption of home healthcare, expansion of remote patient monitoring programs, and growing prevalence of hypertension and cardiovascular diseases. Rising integration of Bluetooth- and cellular-enabled blood pressure monitors with telehealth platforms, supported by favorable reimbursement policies for RPM services, is further accelerating market growth.

Europe Smart Blood Pressure Monitoring Devices Market Trends

The Europe smart blood pressure monitoring devices industry is driven by the increasing adoption of digital health technologies, the growing aging population, and the rising demand for home-based chronic disease management. Strong regulatory support for connected medical devices, expanding telehealth services, and increasing awareness of preventive cardiovascular care are contributing to the market's growth across the region.

The smart blood pressure monitoring devices market in the UK is driven by NHS initiatives promoting remote patient monitoring and virtual healthcare services. Increasing adoption of connected medical devices, growing use of digital health applications, and rising prevalence of hypertension are supporting demand for smart blood pressure monitoring solutions across home and clinical settings.

The Germany smart blood pressure monitoring devices market is growing significantly due to increasing adoption of connected healthcare technologies, strong medical device manufacturing capabilities, and rising demand for home-based blood pressure monitoring. Government support for healthcare digitization and expanding telemedicine services are further encouraging the adoption of smart monitoring devices.

Asia Pacific Smart Blood Pressure Monitoring Devices Market Trends

Asia Pacific is expected to grow at the fastest CAGR of 13.2% over the forecast period from 2026 to 2033. Market growth is driven by the rising prevalence of hypertension, improving healthcare infrastructure, increasing adoption of smartphones and connected medical devices, and expanding government initiatives promoting digital healthcare. Growing healthcare expenditure and rising awareness of preventive health management are further supporting market expansion.

The smart blood pressure monitoring devices market in Japan is witnessing significant growth due to its rapidly aging population, high prevalence of hypertension, and strong adoption of home healthcare technologies. The country's dominance in medical device innovation and increasing use of connected health platforms are encouraging the adoption of AI-enabled and Bluetooth-connected blood pressure monitoring devices.

The China smart blood pressure monitoring devices market is experiencing strong growth, driven by the rising prevalence of hypertension, the rapid expansion of connected healthcare technologies, and the increasing adoption of home-based health monitoring devices. Government initiatives under the Healthy China 2030 strategy, along with growing investments in telemedicine, digital health infrastructure, and remote patient monitoring, are encouraging the adoption of smart blood pressure monitoring solutions across both urban and rural healthcare settings.

Latin America Smart Blood Pressure Monitoring Devices Market Trends

The Latin America smart blood pressure monitoring devices industry’s growth is driven by the increasing prevalence of hypertension, expanding access to home healthcare services, and growing adoption of connected medical devices. Rising healthcare investments and improving awareness of chronic disease management are supporting demand for smart blood pressure monitoring solutions across the region.

Middle East & Africa Smart Blood Pressure Monitoring Devices Market Trends

The smart blood pressure monitoring devices industry in the Middle East & Africa is witnessing steady growth due to increasing healthcare modernization initiatives, rising adoption of digital health technologies, and growing demand for remote patient monitoring. Improving healthcare infrastructure, expanding telemedicine services, and increasing awareness of cardiovascular disease prevention are creating new opportunities for market growth.

Key Smart Blood Pressure Monitoring Devices Company Insights

Key industry players are adopting various strategies, continuously innovating and introducing AI-enabled, Bluetooth-, Wi-Fi-, and cellular-connected smart blood pressure monitoring devices to strengthen their market position. Companies are focusing on integrating remote patient monitoring, mobile health applications, and digital health ecosystems to improve hypertension management and long-term cardiovascular care. Strategic initiatives such as new product launches, partnerships, acquisitions, and geographic expansion are enabling manufacturers to enhance their product portfolios.

Key Smart Blood Pressure Monitoring Devices Companies

The following key companies have been profiled for this study of the smart blood pressure monitoring devices market.

• Omron Healthcare

• A&D Company, Ltd.

• Withings

• iHealth Labs Inc.

• Qardio, Inc.

• Microlife Corporation

• Beurer GmbH

• Rossmax International Ltd.

• ForaCare Inc.

• Yuwell Medical

• Andon Health Co., Ltd. (iHealth OEM)

• Viatom Technology Co., Ltd.

Recent Developments

• In June 2026, Omron Healthcare acquired Life Log Technology, Inc., developer of the AI-powered Calomeal nutrition management app, to strengthen its digital health ecosystem. The acquisition integrates AI-driven nutrition and lifestyle insights with OMRON Connect and connected blood pressure monitoring solutions to support personalized chronic disease management and preventive cardiovascular care.

• In May 2026, Esperto Medical received a Phase I SBIR award from ARPA-H to develop a wearable, wireless continuous blood pressure monitor based on its proprietary Resonance Sonomanometry (RSM) technology. The device is designed to provide non-invasive, calibration-free blood pressure monitoring, supporting accurate remote patient monitoring and long-term hypertension management.

“This ARPA-H award directly aligns with Esperto’s strategy of translating the RSM technology into a wearable remote patient monitoring device, “Because RSM measures blood pressure directly rather than inferring it from other physiologic signals, and because it requires no calibration, we believe it offers significant advantages as a user-friendly and clinically reliable remote monitoring solution.”

- Alaina Rajagopal, Co-Founder and Chief Medical Officer of Esperto Medical.

Global Smart Blood Pressure Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart blood pressure monitoring devicesmarket report based on type, technology, end use, and region:

• Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Upper Arm Blood Pressure Monitor

  • Wrist Blood Pressure Monitor

  • Finger Blood Pressure Monitor

• Technology Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Wi-Fi Based

  • Bluetooth Based

  • Cellular-enabled Devices (4G/5G)

• End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Hospitals

  • Ambulatory Surgery Centers

  • Home Care Settings

• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The smart blood pressure monitoring devices market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each smart blood pressure monitoring devices segment quantified using the revenue-capture definitions in the table below.

Customization Table

This report has been delivered with the following In-depth customizations